Stockreport

Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [CNBC]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Benoit Tessier | Reuters Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the ?French drugmaker said on Wednesd [Read more]